Deletion polymorphism at the angiotensin-converting enzyme gene in Turkish patients with coronary artery disease

被引:30
作者
Akar, N
Aras, Ö
Ömürlü, K
Cin, S
机构
[1] Ankara Univ, Dept Pediat Mol Genet, TR-06100 Ankara, Turkey
[2] Ankara Univ, Dept Cardiol, TR-06100 Ankara, Turkey
关键词
ACE gene; angiotensinogen; coronary arteriosclerosis; gene;
D O I
10.1080/00365519850186292
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Coronary artery disease (CAD) is a multifactorial disease in which genetic and environmental factors play an important role. These factors differ in each population. This study was carried out to determine whether there is an association between insertion/deletion (I/D) polymorphism and CAD in Turkish patients from Ankara. An I/D polymorphism in intron 16 of the gene coding for the angiotensin-converting enzyme (ACE) has been used to study the role of this gene in the aetiology of coronary atherosclerosis and hypertension. As there are no existing data for the Turkish population, we studied the I/D polymorphism of the ACE gene in 218 patients with CAD and 107 controls. Polymerase chain reaction (PCR) was used for genotyping the I and D alleles. The DD polymorphism of the ACE gene was significantly different between CAD subjects (0.733) and controls (0.612) (p = 0.002). The observed heterozygosity was 29.3% and 43.9% and D allele frequency was 0.733 and 0.612, respectively. There was a significantly higher D allele (p = 0.03) in III patients with myocardial infarction (MI) compared with controls. Furthermore, MI localization also gave a significance of p = 0.002 for inferior MI but not for anterior MT (p = 0.83). Forty-three hypertension patients had a D allele frequency of 0.767 which was significantly different from control (p = 0.01). These data provide further evidence for the association of D allele and CAD in a Turkish population.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 25 条
[1]
BARLEY J, 1994, J HYPERTENS, V12, P955
[2]
BERGE KE, 1994, CLIN GENET, V46, P102
[3]
BOHN M, 1993, CLIN GENET, V44, P292
[4]
DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[5]
CAMBIEN F, 1995, EUR HEART J S, V16, P12
[6]
ANGIOTENSIN-I-CONVERTING ENZYME IN HUMAN CIRCULATING MONONUCLEAR-CELLS - GENETIC-POLYMORPHISM OF EXPRESSION IN LYMPHOCYTES-T [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
LOPEZ, M ;
ALHENCGELAS, F .
BIOCHEMICAL JOURNAL, 1993, 290 :33-40
[7]
HARRISWARRICK R, 1993, EARLY MUSIC, V21, P355
[8]
ASSOCIATION ANALYSIS OF A POLYMORPHISM OF THE ANGIOTENSIN CONVERTING ENZYME GENE WITH ESSENTIAL-HYPERTENSION IN THE JAPANESE POPULATION [J].
HIGASHIMORI, K ;
ZHAO, Y ;
HIGAKI, J ;
KAMITANI, A ;
KATSUYA, T ;
NAKURA, J ;
MIKI, T ;
MIKAMI, H ;
OGIHARA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) :399-404
[9]
Hong SH, 1997, CLIN GENET, V51, P35
[10]
A PROSPECTIVE EVALUATION OF AN ANGIOTENSIN-CONVERTING-ENZYME GENE POLYMORPHISM AND THE RISK OF ISCHEMIC-HEART-DISEASE [J].
LINDPAINTNER, K ;
PFEFFER, MA ;
KREUTZ, R ;
STAMPFER, MJ ;
GRODSTEIN, F ;
LAMOTTE, F ;
BURING, J ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :706-711